Tigris Ventures
Tigris Ventures is a seed-stage investment firm and venture incubator based in Houston, Texas, with a focus on identifying early-stage opportunities in the healthcare and environmental sectors, primarily in Southern California. Established in 2012, the firm manages over $20 million in capital, investing its own resources in ventures that demonstrate potential for significant impact and relatively modest exit valuations, typically between $2 million and $20 million. Tigris Ventures not only provides financial backing but also incubates certain start-ups, offering access to shared resources such as a development laboratory, CAD capabilities, and legal support. The firm evaluates investments based on criteria including innovation impact, intellectual property strength, market potential, and management experience, while engaging potential exit partners during the evaluation process to mitigate risk and enhance the likelihood of successful outcomes.
Omniome, Inc. is a biotechnology company based in San Diego, California, focused on developing a DNA sequencing platform that aims to deliver high accuracy in clinical sequencing. Founded in 2013, the company utilizes its proprietary Sequencing By Binding technology, which enhances nucleotide and DNA matching by harnessing the natural capabilities of polymerase. This innovative approach allows researchers to obtain accurate and rapid sequencing results at a lower cost, with the potential to significantly advance cancer diagnostics. Omniome is supported by prominent life sciences venture investors and is committed to becoming a trusted leader in the field of DNA sequencing.
Alastin Skincare
Venture Round in 2019
Alastin Skincare, founded in 2015 and based in Carlsbad, California, specializes in innovative and clinically validated skincare products designed to correct, protect, and maintain healthy skin. The company produces topical skincare solutions that enhance both ablative and non-ablative rejuvenating procedures. Utilizing a proprietary blend of peptides and other scientifically-backed ingredients, Alastin's products support the skin's natural regenerative processes. Their offerings are specifically formulated for use by dermatologists and plastic surgeons, ensuring that patients receive effective treatments that promote long-term skin health. Alastin Skincare is dedicated to reawakening the skin’s youthful qualities through advanced technology and rigorous clinical testing.
Tear Film Innovations
Series A in 2017
Tear Film Innovations Inc. is a medical device company based in San Diego, California, specializing in the treatment of evaporative dry eye and related conditions such as meibomian gland dysfunction (MGD) and blepharitis. Founded in 2014, the company has developed the iLux Dry Eye Treatment System, a handheld device that allows eye care professionals to quickly evaluate and treat dry eye patients in under ten minutes. The iLux system uses targeted heating and compression to unblock meibomian glands, addressing the most common form of dry eye that affects over 330 million people worldwide. Additionally, the company offers BlephaRx, which targets both the symptoms and underlying causes of evaporative dry eye. As of December 2018, Tear Film Innovations operates as a subsidiary of Alcon, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.